000 | 01949 a2200577 4500 | ||
---|---|---|---|
005 | 20250515064206.0 | ||
264 | 0 | _c20071106 | |
008 | 200711s 0 0 eng d | ||
022 | _a0006-4971 | ||
024 | 7 |
_a10.1182/blood-2006-12-062927 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhao, Xiaobin | |
245 | 0 | 0 |
_aTargeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. _h[electronic resource] |
260 |
_bBlood _cOct 2007 |
||
300 |
_a2569-77 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Neoplasm _ximmunology |
650 | 0 | 4 |
_aAntibody-Dependent Cell Cytotoxicity _ximmunology |
650 | 0 | 4 |
_aAntigens, CD _xgenetics |
650 | 0 | 4 |
_aAntigens, CD19 _xmetabolism |
650 | 0 | 4 |
_aAntigens, Neoplasm _xgenetics |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aCaspases _xmetabolism |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 | _aTetraspanins |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aLapalombella, Rosa | |
700 | 1 | _aJoshi, Trupti | |
700 | 1 | _aCheney, Carolyn | |
700 | 1 | _aGowda, Aruna | |
700 | 1 | _aHayden-Ledbetter, Martha S | |
700 | 1 | _aBaum, Peter R | |
700 | 1 | _aLin, Thomas S | |
700 | 1 | _aJarjoura, David | |
700 | 1 | _aLehman, Amy | |
700 | 1 | _aKussewitt, Donna | |
700 | 1 | _aLee, Robert J | |
700 | 1 | _aCaligiuri, Michael A | |
700 | 1 | _aTridandapani, Susheela | |
700 | 1 | _aMuthusamy, Natarajan | |
700 | 1 | _aByrd, John C | |
773 | 0 |
_tBlood _gvol. 110 _gno. 7 _gp. 2569-77 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2006-12-062927 _zAvailable from publisher's website |
999 |
_c16990293 _d16990293 |